On Dec 27, 2021 VLP Therapeutics closed a Series A round and raised $21,000,000 from Miyako Capital, MUFG Bank, Nobelpharma, Robert Hisaoka, SK Impact Fund, […]
Post-IPO Debt – LYSOGENE
On Dec 24, 2021 LYSOGENE closed a Post-IPO Debt round and raised €3,000,000 from European Investment Bank, featuring lead investors European Investment Bank. About the […]
Post-IPO Debt – IMV Inc
On Dec 20, 2021 IMV Inc closed a Post-IPO Debt round and raised $25,000,000 from Horizon Technology Finance, featuring lead investors Horizon Technology Finance. About […]
Post-IPO Equity – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Post-IPO Equity round and raised €15,000,000 from European Innovation Council, featuring lead investors European Innovation Council. About […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Startup Interview – Genz Biotechnology
As part of the startup Interview series, we are going to interview Mr. Umut Ağyüz from GENZ Biotechnology, a London-headquartered spin-off BioTech company developing novel solutions from in […]
Series A – Mana Therapeutics
On Nov 30, 2021 Mana Therapeutics closed a Series A round and raised $7,000,000 from J&W Partners and SK Securities. About the company: Mana Therapeutics […]
Debt Financing – Mana Therapeutics
On Nov 30, 2021 Mana Therapeutics closed a Debt Financing round and raised $7,500,000 from Silicon Valley Bank, featuring lead investors Silicon Valley Bank. About […]
Dicerna Pharmaceuticals acquired by Novo Nordisk
Nov 18, 2021 Novo Nordisk has entered into an agreement to acquire Dicerna Pharmaceuticals in a $3,300,000,000 deal. Novo Nordisk based at Bagsværd, Hovedstaden, Denmark. […]
